Microbiome competitive landscape, technology and pipeline analysis slide share
-
Upload
delveinsight-business-research -
Category
Healthcare
-
view
179 -
download
0
Transcript of Microbiome competitive landscape, technology and pipeline analysis slide share
![Page 1: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/1.jpg)
Microbiome - Competitive Landscape, Technology and Pipeline Analysis
2017
![Page 2: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/2.jpg)
3D STEPS
Microbiome
Microbiome refers to collection of microbes and their interaction with the human body.
They tend play an important role in human physiology and disease.
The market of microbiome therapies is progressing rapidly. Various companies are getting on
the action, aiming to target microbes to treat various types of diseases.
Human body possess number of different species of bacteria and fungi which
help in digesting food, preventing infections, perform numerous life-supporting tasks. Microbes
can also be harmful to their human hosts.
What is Microbiome?
DelveInsight © 2017 | All rights reserved
![Page 3: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/3.jpg)
There are total 70+ drugs in pipeline. 30+ products are in Pre-
clinical, 15+ products are in Discovery stage of development and a few
products are in Unknown stage of
development.
Key Market Driversfor microbiome are
Advanced Technology as well
Increased Collaborations &
Acquisitions
Key Market Barriers are Optimization of dosing & mitigation of Toxicity as well Scalability and
cost to ensure accessibility
& affordability
Most Prominent Indications includes Clostridium Difficile
Infection, Inflammatory Bowel Disease,
Prediabetes, Type II Diabetes Mellitus
Some Key Findings from the report
DelveInsight © 2017 | All rights reserved
![Page 4: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/4.jpg)
CHART
“Synlogic is developing 5+
drugs that address disease
by targeting gut microbiome
using their synthetic biotic
approach. They collaborated
to create innovative
synthetic biotic for the
treatment of major diseases”
Some Key Findings from the report
50% Apogenix
DelveInsight © 2017 | All rights reserved
0
5
10
15
20
25
30
NU
MB
ER O
F P
RO
DU
CTS
THERAPY AREA
Number of Products (N) with Therapy AreaThe market of microbiome therapies is progressing rapidly. Various companies
are getting onthe action, aiming to target microbes to
treat various types of diseases. The therapeutics are used across many therapy areas. Major therapy areas
focused by pipeline drugs for microbiome are Gastrointestinal, Metabolic Disorders,
Infectious Disease, Dermatology.
![Page 5: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/5.jpg)
CHART
Some Key Findings from the report Conti.
50% Apogenix
DelveInsight © 2017 | All rights reserved
0
2
4
6
8
Nu
mb
er
of
Pro
du
cts
Technology
The technology used by each company is given below. The maximum product isbeing developed by using MiNE (Microbiome isolates and Novel Extracts)platform of Quorum Innovations followed by Assembly Biosciences. EnteromeBioscience, Microbiome therapeutics and Immuron is developing two productsby using their own technology.
![Page 6: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/6.jpg)
Role of Microbiota in Health and Disease
DelveInsight © 2017 | All rights reserved
DIAGRAM
Role in GastroIntestinal
Disease
Role in Metabolic Disorders
Role in Inflammatory
Bowel Diseases
Role in Cancers
Role in Diabetes
Role in Cardiovascular
diseases
Microbiota
![Page 7: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/7.jpg)
Overview of the global Microbiome pipeline scenario, products and associated companies information
Coverage of global Microbiome under development as well as Competitive landscape of products for key players and related indications
Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, MOA, route of administration and molecule type etc.
Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation
Highlights of licensing & collaboration opportunities and funding details along with Microbiome technologies and innovative companies
Microbiome: Report Highlights
DelveInsight © 2017 | All rights reserved
![Page 8: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/8.jpg)
Complete Information
DelveInsight © 2017 | All rights reserved
For complete information please click below
OrWrite to us at
CLICK HERE
![Page 9: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/9.jpg)
About DelveInsight
Vision
“insight across the value chain”to help organizations make
important business decisionsthrough the use and analysis of actionable market intelligence
Mission
To be the most trusted marketing research firm & business consulting firm
worldwide.To be a renowned and premier
data driven solution providers among Pharma & Biotech
companies.
DelveInsight, market research and consulting
firm, provides end to end comprehensive solutions
to the Life Science Industry.
We help our customers in best decision making through our expertise in research & analysis and
comes out with unmatched data &
forecasts
DelveInsight © 2017 | All rights reserved
![Page 10: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/10.jpg)
• Trends Analysis
• Physicians & Patients Perception
• KOLs
Service Offerings at DelveInsight
DelveInsight © 2017 | All rights reserved
Comprehensive solution for strategic business decisions
• Market Size
• Market Dynamics
• Market Assessment
Access over 3000+ Reports
• API
• Market & Pipeline
• Indication & Epidemiology
• Drug Sales Forecast
• Indication Forecast
• Late Stage Pipeline Analysis• Asset Prioritization
• Brand Optimization
• Portfolio Expansion
Opportunity Assessment for
• Licensing
• Market Access
• Partnership
• Competitive landscape
• Clinical Trials
• Therapeutic Assessment
• Primary Analytics
• News-Letters
• Conference Tracking
• Clinical Trials Tracking
Market
Intelligence
Consulting
SociAlytics
Pipeline
Forecasting
![Page 11: Microbiome competitive landscape, technology and pipeline analysis slide share](https://reader033.fdocuments.net/reader033/viewer/2022051710/5a64e6b57f8b9ac21c8b7a19/html5/thumbnails/11.jpg)
11
Contact Us:[email protected]+91-11-4568 9769www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight
DelveInsight © 2017 | All rights reserved
Contact Us